Hansoh Pharmaceutical Group Company Limited (HKG:3692)

HKG:3692 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	13,189	12,261	10,104	9,382	9,935	8,690
Revenue Growth (YoY)	9.02%	21.35%	7.69%	-5.56%	14.32%	0.09%
Cost of Revenue	1,208	1,117	1,033	870.19	870.39	803.41
Gross Profit	11,981	11,144	9,071	8,512	9,065	7,887
Selling, General & Admin	4,595	4,508	4,241	4,148	4,371	3,862
Research & Development	2,946	2,702	2,097	1,693	1,797	1,252
Other Operating Expenses	-18.75	31.98	53.9	63.73	75.91	-
Operating Expenses	7,522	7,242	6,392	5,905	6,244	5,114
Operating Income	4,459	3,902	2,679	2,607	2,821	2,773
Interest Expense	-3.38	-6.69	-66.68	-58.14	-52.82	-1.65
Interest & Investment Income	1,117	1,046	1,020	331.52	253.85	163.92
Earnings From Equity Investments	-	-	-2.12	-13.86	-	-
Currency Exchange Gain (Loss)	-8.66	21.43	4.57	44.56	-9.31	63.37
Other Non Operating Income (Expenses)	113.9	87.35	105.25	117.17	139.34	10.87
EBT Excluding Unusual Items	5,678	5,050	3,741	3,029	3,152	3,009
Gain (Loss) on Sale of Investments	-25.27	61.27	158.22	67.58	144.49	88.91
Gain (Loss) on Sale of Assets	7.13	5.72	2.1	11.24	3.94	-0.04
Asset Writedown	-4.31	-31.98	-	-	-	-
Other Unusual Items	-	-	-134.71	-159.12	-	-
Pretax Income	5,655	5,085	3,766	2,948	3,300	3,098
Income Tax Expense	873.92	713.36	488.65	364.68	587.18	529.39
Net Income	4,781	4,372	3,278	2,584	2,713	2,569
Net Income to Common	4,781	4,372	3,278	2,584	2,713	2,569
Net Income Growth	1.42%	33.39%	26.85%	-4.76%	5.61%	0.48%
Shares Outstanding (Basic)	5,936	5,930	5,925	5,916	5,921	5,876
Shares Outstanding (Diluted)	5,955	5,950	6,020	5,929	5,998	5,878
Shares Change (YoY)	-1.10%	-1.16%	1.52%	-1.14%	2.04%	7.31%
EPS (Basic)	0.81	0.74	0.55	0.44	0.46	0.44
EPS (Diluted)	0.80	0.73	0.52	0.44	0.44	0.44
EPS Growth	5.94%	40.62%	19.65%	-1.29%	1.21%	-6.34%
Free Cash Flow	-	3,640	2,897	2,468	2,117	962.83
Free Cash Flow Per Share	-	0.61	0.48	0.42	0.35	0.16
Dividend Per Share	0.340	0.316	0.193	0.088	0.073	0.065
Dividend Growth	8.08%	63.53%	118.47%	20.84%	12.44%	-
Gross Margin	90.84%	90.89%	89.78%	90.72%	91.24%	90.75%
Operating Margin	33.81%	31.83%	26.52%	27.79%	28.39%	31.91%
Profit Margin	36.25%	35.66%	32.44%	27.54%	27.31%	29.56%
Free Cash Flow Margin	-	29.69%	28.67%	26.31%	21.31%	11.08%
EBITDA	4,817	4,278	3,025	2,932	3,084	2,989
EBITDA Margin	36.52%	34.89%	29.94%	31.25%	31.04%	34.40%
D&A For EBITDA	358.3	375.57	345.63	324.37	263.42	216.35
EBIT	4,459	3,902	2,679	2,607	2,821	2,773
EBIT Margin	33.81%	31.83%	26.52%	27.79%	28.39%	31.91%
Effective Tax Rate	15.45%	14.03%	12.97%	12.37%	17.79%	17.09%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.